文献速递外周动脉疾病

冷冻保存动脉同种移植物用于严重肢体缺血远端旁路移植的十年经验

Ten Year Experience of Using Cryopreserved Arterial Allografts for Distal Bypass in Critical Limb Ischaemia.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2019-05-23

回顾性分析2006至2015年42例因严重肢体缺血接受冷冻保存动脉同种移植物远端旁路移植的患者,所有患者均缺乏自体大隐静脉或替代自体导管。结果显示5年次级通畅率57%、保肢率82%,30天无主要不良心脏事件,提示在无静脉导管时动脉同种移植物是可行的保肢替代选择。

要点

  • 无自体静脉导管时,冷冻保存动脉同种移植物可作为严重肢体缺血远端旁路的替代选择。
  • 5年次级通畅率57%,保肢率82%,生存率34%。
  • 30天主要截肢1例,无主要不良心脏事件,长期随访主要截肢共6例。

核心结论

  • 尽管2年初级通畅率较低,动脉同种植物的次级通畅率对于远端旁路移植是可接受的。
  • 冷冻保存动脉同种移植物是在缺乏静脉导管时用于保肢远端旁路移植的合适替代选择,可改善保肢率并可能改善生活质量。

研究设计与样本

  • 所有患者均无法获得自体大隐静脉或替代自体导管。
  • 观察患者生存、保肢和同种移植物通畅情况,采用Kaplan-Meier图分析。

主要发现

  • 次级通畅率估计值在1年、2年和5年分别为81%、73%和57%。
  • 初级通畅率估计值在1年、2年和5年分别为60%、56%和26%。
  • 保肢率估计值在1年、2年和5年分别为89%、89%和82%。
  • 生存率估计值在1年、2年和5年分别为92%、76%和34%。
  • 30天主要截肢1例,主要不良心脏事件0例;长期随访期间发生6例主要截肢。

临床怎么用

  • 对于严重肢体缺血且缺乏自体静脉导管的患者,可考虑使用冷冻保存动脉同种移植物进行远端旁路移植以保肢。
  • 需告知患者初级通畅率较低,但次级通畅率和保肢率可接受。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/BACKGROUND: In critical limb ischaemia (CLI), current guidelines recommend revascularisation whenever possible, preferentially through endovascular means. However, in the case of long occlusions or failed endovascular attempts, distal bypasses still have a place. Single segment great saphenous vein (GSV), which provides the best conduit, is often not available and currently there is no consensus about the best alternative graft. METHODS: From January 2006 to December 2015, 42 cryopreserved arterial allografts were used for a distal bypass. Autologous GSVs or alternative autologous conduits were unavailable for all patients. The patients were observed for survival, limb salvage, and allograft patency. The results were analysed with Kaplan-Meier graphs. RESULTS: Estimates of secondary patency at one, two and five years were 81%, 73%, and 57%, respectively. Estimates of primary patency rates at one, two and five years were 60%, 56%, and 26%, respectively. Estimates of limb salvage rates at one, two and five years were 89%, 89%, and 82%, respectively. Estimates of survival rates at one, two and five years were 92%, 76% and 34%, respectively. At 30 days, major amputations and major adverse cardiac events were one and zero, respectively. Six major amputations occurred during the long-term follow up. CONCLUSION: Despite a low primary patency rate at two years, the secondary patency of arterial allografts is acceptable for distal bypasses. This suggests that cryopreserved arterial allografts are a suitable alternative for limb saving distal bypasses in the absence of venous conduits, improving limb salvage rates and, possibly, quality of life.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Masmejan S, Deslarzes-Dubuis C, Petitprez S, et al. Ten Year Experience of Using Cryopreserved Arterial Allografts for Distal Bypass in Critical Limb Ischaemia. Eur J Vasc Endovasc Surg. 2019. PMID: 31130420. doi:10.1016/j.ejvs.2018.11.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。